Two distinct major facilitator superfamily drug efflux pumps mediate chloramphenicol resistance in Streptomyces coelicolor.
Chloramphenicol, florfenicol, and thiamphenicol are used as antibacterial drugs in clinical and veterinary medicine. Two efflux pumps of the major facilitator superfamily encoded by the cmlR1 and cmlR2 genes mediate resistance to these antibiotics in Streptomyces coelicolor, a close relative of Mycobacterium tuberculosis. The transcription of both genes was observed by reverse transcription-PCR. Disruption of cmlR1 decreased the chloramphenicol MIC 1.6-fold, while disruption of cmlR2 lowered the MIC 16-fold. The chloramphenicol MIC of wild-type S. coelicolor decreased fourfold and eightfold in the presence of reserpine and Phe-Arg-beta-naphthylamide, respectively. These compounds are known to potentiate the activity of some antibacterial drugs via efflux pump inhibition. While reserpine is known to potentiate drug activity against gram-positive bacteria, this is the first time that Phe-Arg-beta-naphthylamide has been shown to potentiate drug activity against a gram-positive bacterium.
Vecchione
James J
JJ
Department of Chemistry, Brown University, 324 Brook Street, Providence, RI 02912, USA.
Alexander
Blair
B
Sello
Jason K
JK
D001426:Bacterial Proteins / Q000235:genetics / Q000502:physiology*; D002702:Chloramphenicol Resistance; D004151:Dipeptides / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D048372:Streptomyces coelicolor / Q000187:drug effects*
D001426:Bacterial Proteins; D004151:Dipeptides; C474925:phenylalanylarginine-naphthylamide; D012110:Reserpine
Microbiology (Reading). 2002 Oct;148(Pt 10):2967-2973
12368430
Mol Microbiol. 1997 Jan;23(1):169-78
9004230
Mol Microbiol. 1991 Nov;5(11):2789-97
1779766
J Antimicrob Chemother. 2009 Jan;63(1):103-8
19010827
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1541-6
12563033
Antimicrob Agents Chemother. 2004 May;48(5):1797-802
15105137
J Antimicrob Chemother. 2003 Jan;51(1):9-11
12493781
J Antimicrob Chemother. 2004 Mar;53(3):544-5
14762057
J Antimicrob Chemother. 1998 Dec;42(6):807-10
10052906
J Bacteriol. 1998 Aug;180(16):4017-23
9696745
Antimicrob Agents Chemother. 1992 Feb;36(2):484-5
1605617
Mol Microbiol. 1995 Sep;17(5):989-99
8596448
Science. 2008 Jul 18;321(5887):365-7
18635792
J Bacteriol. 1998 Nov;180(22):6072-5
9811673
Biochem Pharmacol. 2006 Mar 30;71(7):910-8
16427026
Antimicrob Agents Chemother. 2001 Jan;45(1):105-16
11120952
J Biol Chem. 2005 Apr 1;280(13):13055-61
15632111
Nat Rev Drug Discov. 2007 Jan;6(1):56-65
17159924
J Bacteriol. 2008 Sep;190(18):6253-7
18621902
Antimicrob Agents Chemother. 2008 Jul;52(7):2503-11
18458127
J Bacteriol. 2003 Sep;185(17):5320-3
12923110
J Med Chem. 1999 Dec 2;42(24):4928-31
10585202
Mol Microbiol. 2007 Feb;63(4):951-61
17338074
Nature. 2002 May 9;417(6885):141-7
12000953
Science. 2006 Jan 20;311(5759):374-7
16424339
J Antimicrob Chemother. 2006 May;57(5):970-4
16531429
J Antimicrob Chemother. 1997 Sep;40(3):458-60
9338508
Antimicrob Agents Chemother. 1999 Feb;43(2):287-91
9925520
Antimicrob Agents Chemother. 2005 Jul;49(7):2965-71
15980376
J Antimicrob Chemother. 2007 Jun;59(6):1223-9
17229832